Market Overview:
The global bench-top HbA1c analyzers market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of diabetes, technological advancements in HbA1c analyzers, and rising demand for point-of-care testing. However, the high cost of bench-top HbA1c analyzers may restrain the market growth. Based on type, the global bench-top HbA1c analyzers market is segmented into ion exchange chromatography, immunoassay, boronate affinity technology and others. Ion exchange chromatography held a dominant share in 2017 and is expected to maintain its dominance during the forecast period owing to its high accuracy and precision levels. Immunoassay is another key segment of this market due to its growing popularity for home use diagnostics.
Product Definition:
Bench-top HbA1c Analyzers are medical devices that are used to measure the level of glycated hemoglobin in a person's blood. This measurement can be used to help determine how well a person's diabetes is being managed. The importance of Bench-top HbA1c Analyzers is that they provide an accurate measurement of a person's glycated hemoglobin level, which can help healthcare professionals make informed decisions about their treatment plan.
Ion Exchange Chromatography:
Ion exchange chromatography is a type of separation technique used for the separation of proteins and peptide molecules. The ion exchange resin binds to the desired compound, in this case glucose, and allows selective elution based on polarity. This method has been widely accepted as an effective tool for measuring blood sugar levels in patients suffering from diabetes mellitus.
Immunoassay:
An immunoassay is a technique that makes use of antibodies and their binding partners to identify, measure, or detect molecules such as proteins, peptides hormones vitamins enzymes etc. The technology involves the usage of various reagents and kits which are specific to certain analytes. It is an analytical procedure used for detecting the presence or measuring the quantity of an analyte in a sample by using different types of antibodies coupled with some reagents.
Application Insights:
The market is segmented into hospitals and diagnostic centers. Hospitals held the largest share in 2017 owing to the presence of prominent players such as Siemens Healthineers, iHealth Technologies, and LabCorp among others. These companies offer a wide range of products for HBV, HCV, HIV testing and other chronic diseases testing.
On the other hand, diagnostic centers are expected to witness lucrative growth over the forecast period due to increasing awareness about preventable diseases along with rising incidences of target conditions such as diabetes & its complications across various regions including North America and Europe. Furthermore, an increase in patient visits due to rapid urbanization coupled with limited healthcare resources has led to an increased number of blood glucose tests being performed at outpatient clinics which is further anticipated to boost product demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increasing adoption rate of advanced technologies, and high healthcare expenditure in this region. In addition, growing awareness about chronic diseases management is expected to propel demand for blood glucose monitoring devices over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income levels and improving economic conditions in emerging countries such as India and China. Furthermore, government initiatives encouraging private investments are likely to boost regional product penetration rates over the next eight years. For instance, Novo Nordisk has collaborated with local partners such as Genzyme Corporation for diabetes care management program distribution across Asia Pacific countries since 2015’s BMG Diabetes campaign until 2018's Endeavor campaign (Endeavor XXXXXXX).
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is expected to drive the demand for bench-top HbA1c analyzers in the coming years.
- Technological advancements: Bench-top HbA1c analyzers are becoming more and more sophisticated with each passing day, thanks to technological advancements. This is likely to boost their demand in the near future.
- Growing awareness about diabetes: There has been a growing awareness about diabetes in recent years, thanks to various campaigns by health organizations and governments across the world. This is likely to fuel the demand for bench-top HbA1c analyzers in the coming years as well.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bench-top HbA1c Analyzers Market Research Report
By Type
Ion Exchange Chromatography, Immunoassay, Boronate Affinity Technology, Others
By Application
Hospitals, Diagnostic Centers
By Companies
Abbott, Roche, Bio-Rad Laboratories, Tosoh, ARKRAY, Meril Life Sciences, Erba Mannheim
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Bench-top HbA1c Analyzers Market Report Segments:
The global Bench-top HbA1c Analyzers market is segmented on the basis of:
Types
Ion Exchange Chromatography, Immunoassay, Boronate Affinity Technology, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Roche
- Bio-Rad Laboratories
- Tosoh
- ARKRAY
- Meril Life Sciences
- Erba Mannheim
Highlights of The Bench-top HbA1c Analyzers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ion Exchange Chromatography
- Immunoassay
- Boronate Affinity Technology
- Others
- By Application:
- Hospitals
- Diagnostic Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bench-top HbA1c Analyzers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bench-top HbA1c analyzers are medical devices that measure blood sugar levels. They are used to diagnose and monitor diabetes.
Some of the key players operating in the bench-top hba1c analyzers market are Abbott, Roche, Bio-Rad Laboratories, Tosoh, ARKRAY, Meril Life Sciences, Erba Mannheim.
The bench-top hba1c analyzers market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bench-top HbA1c Analyzers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bench-top HbA1c Analyzers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bench-top HbA1c Analyzers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bench-top HbA1c Analyzers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bench-top HbA1c Analyzers Market Size & Forecast, 2020-2028
4.5.1 Bench-top HbA1c Analyzers Market Size and Y-o-Y Growth
4.5.2 Bench-top HbA1c Analyzers Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Ion Exchange Chromatography
5.2.2 Immunoassay
5.2.3 Boronate Affinity Technology
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bench-top HbA1c Analyzers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bench-top HbA1c Analyzers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Ion Exchange Chromatography
9.6.2 Immunoassay
9.6.3 Boronate Affinity Technology
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Ion Exchange Chromatography
10.6.2 Immunoassay
10.6.3 Boronate Affinity Technology
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Ion Exchange Chromatography
11.6.2 Immunoassay
11.6.3 Boronate Affinity Technology
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Ion Exchange Chromatography
12.6.2 Immunoassay
12.6.3 Boronate Affinity Technology
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Ion Exchange Chromatography
13.6.2 Immunoassay
13.6.3 Boronate Affinity Technology
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bench-top HbA1c Analyzers Market: Competitive Dashboard
14.2 Global Bench-top HbA1c Analyzers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Roche
14.3.3 Bio-Rad Laboratories
14.3.4 Tosoh
14.3.5 ARKRAY
14.3.6 Meril Life Sciences
14.3.7 Erba Mannheim
